Company Company Profile: Established in 2015 Focus on Cardiology intervention andPeripheral intervention. Quickly grown-up, now over 100employees Professional staff from TERUMO and otherleading companies Adquired investment from relativeinstitutions. Small MOQ and short delivery time OEM services supported World-wide acknowledge with FSC, ISO,CE-mark
Zhejiang Barty Medical Co. LTD. establishedin ETDA, Hangzhou in 2015 with registered capital of 20 million Yuan. The totalarea including administration and GMP workshop reaches 5,000 square meters. Our company focuses on R&D, productionand sale of interventional and implantable cardiovascular products withintellectual property such as Drug–eluting PTCA balloon catheter, Drug–eluting PTA balloon catheter, PTCA balloon catheter , PTA ballooncatheter , Drug–elutingperipheral stent and matched products like catheter sheath sets、angiographic catheter、guide catheter. Among them, Drug–eluting PTA balloon catheter andDrug–elutingperipheral stent will fill in gaps in domestic market, and Drug–eluting PTCA balloon catheter willtake place of that from foreign market.
Angiography A catheter is used to inject a radiopaquecontrast agent into blood vessels so that they can be seen on x-rays. Coronary angiography provides informationabout the coronary arteries, which supply the heart with oxygen-rich blood.Coronary angiography is similar to catheterization of the left side of theheart because the coronary arteries branch off the aorta just after it leavesthe left side of the heart (see Blood Supply of the Heart). The two proceduresare almost always done at the same time.